Back to the scorecard

Bloodstream nanobots perform scouting and limited repairs.

Reference judgmentPendingResearch snapshot · October 15, 2026
Source confidence & research status
i
Editorial paraphrase · evidence v0.3. AI-assisted editorial assessments; original book editions not independently collated. Attribution and outcome confidence are recorded separately.

Source state: TEXT CONFIRMED IN LISTED SOURCE.

Attribution confidence
MEDIUM
Outcome confidence · deadline / review
MEDIUM / MEDIUM
Timing confidence / kind
LOW · UNESTABLISHED
Population
Technology markets and relevant users; no universality unless the forecast expressly requires it.

Our reading of the claim

Reference (stated reasonable reading)

Pending

Criterion: Deployed in-body nanorobots scout the bloodstream and carry out limited repair, beyond passive drug nanoparticles.

Deadline: 2029 · Not counted in this comparison

At original deadlineNOT DUE
By review datePARTLY FULFILLED

The verified adaptation puts this version in 2029, so it is pending. Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.

Deadline and follow-up notes

At deadline: The verified adaptation puts this version in 2029, so it is pending.

By review: Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.

Evidence: N29 (opens in a new tab)

View this reading in the scorecard →
01

The forecast and its attribution.

EDITORIAL PARAPHRASE

Bloodstream nanobots perform scouting and limited repairs.

Spiritual Machines: The Merging of Man and Machine — Ray Kurzweil

1999 · Attribution / year unconfirmed
Health care in 2029

AUTHORED ARTICLE THIRD PARTY MIRROR

Source publication: 1999 · Access: text checked

Attributed to Kurzweil; closing note identifies adaptation from The Age of Spiritual Machines (1999). An article mirror, not a scan of the book. Text transcription may contain errors. The article’s dollar amounts must not silently replace differently quoted book versions.

Catalogue entry P02
Open listed source (opens in a new tab)
Normalized claim
Bloodstream nanobots perform scouting and limited repairs.
Success criteria
Deployed in-body nanorobots scout the bloodstream and carry out limited repair, beyond passive drug nanoparticles.
Claim type
Capability
02

Timeline

PREDICTION MADE1999Attributed forecast year; original edition not collated
ORIGINAL TARGET2029Deadline supplied by this assessment
FULL REALIZATION—No achievement year established

UNESTABLISHED: Deadline not yet reached

Outcome at original deadlineNOT DUE
Outcome at reviewPARTLY FULFILLED

Supplied target wording: 2029. The original deadline is preserved if a later forecast revises it. Forecast horizon: not established. Drift is a calendar-year difference, not a precise elapsed duration.

03

The evidence.

CONTEXT · 2026-03-07

Medical microrobots: clinical translation review (opens in a new tab)

Clinical translation, safety and manufacturing challenges; nanoparticles are not autonomous bloodstream repair robots.. Clinical translation, safety and manufacturing challenges; nanoparticles are not autonomous bloodstream repair robots.

Source checked as of 2026-10-15
SCIENTIFIC REVIEW

Source publication: 2026-03-07 · Access: web text or indexed extract checked

Clinical translation, safety and manufacturing challenges; nanoparticles are not autonomous bloodstream repair robots.

Catalogue entry N29

Capability, adoption, and timing

A related breakthrough is not automatically fulfillment. Review must check the actual capability, how widely it was required to be used, the specified technology, and the original deadline. A prototype cannot establish a claim about routine or widespread use.

04

Research notes & history

The disputed 2019 legacy attribution is not silently changed into this 2029 claim; its reconciliation history remains available.

Open questions

  • Original-edition collation remains an attribution task; it does not erase the stated outcome assessment.
Imported from
kurzweil_verification_v0_3_package/predictions.canonical.v0.3.json
Legacy identifier
None
Forecast family
F-NANOBOTS
Parent statement
Not assigned
File checksum
93ae54d9ea2f1bd1817c481b85e2b707812bcd934c74d0f1715fa098d9b5f51b
Inspect preserved source fields
release_record
{"population_scope":"Technology markets and relevant users; no universality unless the forecast expressly requires it.","attribution_confidence":"MEDIUM","interpretation_confidence":"HIGH","outcome_confidence":{"at_deadline":"MEDIUM","at_review":"MEDIUM"},"timing_confidence":"LOW","date_uncertainty_affects_verdict":false,"interpretations":{"reference":{"criterion":"Deployed in-body nanorobots scout the bloodstream and carry out limited repair, beyond passive drug nanoparticles.","at_deadline":"NOT_DUE","at_review":"PARTLY_FULFILLED","rationale":"The verified adaptation puts this version in 2029, so it is pending. Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.","relaxed_or_changed_conditions":[],"kind":"REFERENCE_READING","documented_by_year":null,"at_deadline_rationale":"The verified adaptation puts this version in 2029, so it is pending.","at_review_rationale":"Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.","evidence_source_ids":["N29"],"verdict":"PENDING","same_as_reference":false,"eligible_for_deadline_metrics":false,"deadline_year":2029,"outcome_assessment_complete":true},"strict":{"criterion":"Deployed in-body nanorobots scout the bloodstream and carry out limited repair, beyond passive drug nanoparticles.","at_deadline":"NOT_DUE","at_review":"PARTLY_FULFILLED","rationale":"The verified adaptation puts this version in 2029, so it is pending. Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.","relaxed_or_changed_conditions":[],"kind":"REFERENCE_READING","documented_by_year":null,"at_deadline_rationale":"The verified adaptation puts this version in 2029, so it is pending.","at_review_rationale":"Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.","evidence_source_ids":["N29"],"verdict":"PENDING","same_as_reference":true,"eligible_for_deadline_metrics":false,"deadline_year":2029,"outcome_assessment_complete":true},"broader":{"criterion":"Deployed in-body nanorobots scout the bloodstream and carry out limited repair, beyond passive drug nanoparticles.","at_deadline":"NOT_DUE","at_review":"PARTLY_FULFILLED","rationale":"The verified adaptation puts this version in 2029, so it is pending. Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.","relaxed_or_changed_conditions":[],"kind":"REFERENCE_READING","documented_by_year":null,"at_deadline_rationale":"The verified adaptation puts this version in 2029, so it is pending.","at_review_rationale":"Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.","evidence_source_ids":["N29"],"verdict":"PENDING","same_as_reference":true,"eligible_for_deadline_metrics":false,"deadline_year":2029,"outcome_assessment_complete":true}},"timing":{"first_full_achievement_year":null,"documented_by_year":null,"achievement_interval_years":null,"kind":"UNESTABLISHED","label":"Deadline not yet reached","drift_years":null,"drift_range_years":null},"deduplication":{"is_canonical":true,"is_repeated_identical_claim":false,"counting_unit":"DISTINCT_FORECAST_VERSION","note":"Different deadlines or materially different thresholds remain separate versions; identical legacy repetitions are linked, not recounted."},"revision_history":[{"from_version":"0.2","previous_assessment":{"review_state":"ASSESSED","verdict":"PENDING","as_of":"2026-10-14","at_deadline":"NOT_DUE","at_review":"NOT_ASSESSED","confidence":"MEDIUM","disputed_interpretation":false,"benchmark_ready":true,"rationale":"This checked article places the claim in 2029. The unlocated 2019 versions in the intake remain unresolved separately; this later version must not erase a genuinely earlier forecast should it be found.","first_full_achievement_year":null,"full_achievement_documented_by_year":null,"drift_years":null,"drift_range_years":null,"still_unfulfilled_as_of_review":false,"eligible_for_deadline_metrics":false,"withheld_reason":"Future, unresolved, intrinsically unscorable, or interpretation-dependent; see assessment."},"change_reason":"Complete deadline/current outcome assessment under explicit scope; separate uncertainty from verdict."}],"is_new_in_v03":false,"counting_policy":{"unit":"distinct_forecast_version","identical_repetitions_count_once":true,"alternative_interpretations_count_once":true,"legacy_conditional_rows_count":false},"id":"K024","slug":"k024-bloodstream-nanobots-for-scouting-and-limited-repair","title":"Bloodstream nanobots for scouting and limited repair","prediction_paraphrase":"Bloodstream nanobots perform scouting and limited repairs.","wording_kind":"EDITORIAL_PARAPHRASE","original_quote":null,"primary_category":"Biology & medicine","tags":["nanorobots","clinical deployment"],"subcategory":"Nanomedicine","claim_type":"CAPABILITY","family_id":"F-NANOBOTS","parent_statement_id":null,"legacy_ids":[],"origin":"CONFIRMED_RELATED_VERSION","publication":{"forecast_year":1999,"year_basis":"ARTICLE_ATTRIBUTION","original_book_edition_checked":false,"forecast_year_status":"ATTRIBUTED_ARTICLE_YEAR_NOT_ORIGINAL_BOOK_COLLATION"},"target":{"text":"2029","deadline_year":2029,"precision":"YEAR","year_start":2029,"year_end":2029,"interpretation":null},"source_verification":{"state":"TEXT_CONFIRMED_IN_LISTED_SOURCE","confidence":"MEDIUM","book_text_not_independently_collated":true},"success_criteria":"Deployed in-body nanorobots scout the bloodstream and carry out limited repair, beyond passive drug nanoparticles.","assessment":{"at_deadline_rationale":"The verified adaptation puts this version in 2029, so it is pending.","at_review_rationale":"Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.","verdict_qualifier":null,"outcome_evidence_basis":"DIRECT_AND_CONTEXTUAL_EVIDENCE_WITH_EXPLICIT_EDITORIAL_INTERPRETATION","attribution_is_separate":true,"first_event_date_required_for_verdict":false,"at_review_semantics":"FULL_REALIZATION_HAS_OCCURRED_BY_REVIEW_NOT_NECESSARILY_CURRENT_PRODUCT_SALES","review_state":"EDITORIAL_ASSESSMENT_COMPLETE","verdict":"PENDING","as_of":"2026-10-15","at_deadline":"NOT_DUE","at_review":"PARTLY_FULFILLED","confidence":"MEDIUM","disputed_interpretation":false,"benchmark_ready":false,"rationale":"The verified adaptation puts this version in 2029, so it is pending. Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.","first_full_achievement_year":null,"full_achievement_documented_by_year":null,"drift_years":null,"drift_range_years":null,"still_unfulfilled_as_of_review":true,"eligible_for_deadline_metrics":false,"withheld_reason":"Future deadline; current progress nevertheless assessed."},"prediction_sources":[{"source_id":"P02","locator":"Health care in 2029","role":"FORECAST_ATTRIBUTION"}],"evidence":[{"source_id":"N29","locator":"Clinical translation, safety and manufacturing challenges; nanoparticles are not autonomous bloodstream repair robots.","role":"OUTCOME_EVIDENCE"}],"limitations":"The disputed 2019 legacy attribution is not silently changed into this 2029 claim; its reconciliation history remains available.","open_questions":["Original-edition collation remains an attribution task; it does not erase the stated outcome assessment."],"legacy_relations":[{"legacy_id":"AUD-025","relation":"QUARANTINE_RELATED_VERSION_ONLY"},{"legacy_id":"EXE-015","relation":"QUARANTINE_RELATED_VERSION_ONLY"},{"legacy_id":"DEC-024","relation":"QUARANTINE_RELATED_VERSION_ONLY"}]}

Review history

— Evidence v0.2: PENDING. This checked article places the claim in 2029. The unlocated 2019 versions in the intake remain unresolved separately; this later version must not erase a genuinely earlier forecast should it be found. Change: Complete deadline/current outcome assessment under explicit scope; separate uncertainty from verdict.

— Evidence v0.3: EDITORIAL_ASSESSMENT_COMPLETE; supplied verdict PENDING. The verified adaptation puts this version in 2029, so it is pending. Medical microrobotics has genuine experimental progress but clinical translation and in-body autonomy remain material gaps.

Related forecasts.

No forecast family has been resolved for this record. Related statements and revised deadlines will be linked during research.